Candel Therapeutics Inc
CADL
Market Cap$273.52M
Close$
$0.44
96.6% downside
Current Fair Value
96.6% downsideOvervalued by 96.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $273.52 Million |
|---|---|
| Enterprise Value | $253.31 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.1 |
| Beta | 0.0 |
| Outstanding Shares | 29,347,468 |
| Avg 30 Day Volume | 1,208,774 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.57 |
|---|---|
| PEG | 294.19 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 7915.83 |
| Enterprise Value to EBIT | -7 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.99 |
Revenue Sources
No data
ESG Score
No data
About Candel Therapeutics Inc
2,021 employees